Kent Lai

7PUBLICATIONS
17CO-AUTHORS
Gene and molecular therapyChemical and thermal processes in energy and combustionGlycoconjugatesCancer cell biologyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 30, 2025
Experimental Galactose-1-Phosphate Uridylyltransferase (GALT) mRNA Therapy Improves Motor-Related Phenotypes in a Mouse Model of Classic Galactosemia-A Pilot Study.

Olivia Bellagamba, Aaron J Guo, Xinhua Yan

|Mar 18, 2025
AAV-based gene replacement therapy prevents and halts manifestation of abnormal neurological phenotypes in a novel mouse model of PMM2-CDG.

Mian-Ling Zhong, Kent Lai

|Feb 15, 2025
Reshaping the Treatment Landscape of a Galactose Metabolism Disorder.

M Estela Rubio-Gozalbo, E Naomi Vos, Isabel Rivera

|Feb 13, 2025
Improvement of Mutant Galactose-1-Phosphate Uridylyltransferase (GALT) Activity by FDA-Approved Pharmacochaperones: A Preliminary Study.

Bernardina Scafuri, Stefania Piscosquito, Giulia Giliberti

|Jul 27, 2021
Integrated stress response control of granulosa cell translation and proliferation during normal ovarian follicle development.

Evelyn Llerena Cari, Synneva Hagen-Lillevik, Asma Giornazi

|May 12, 2019
A novel phosphoglucomutase-deficient mouse model reveals aberrant glycosylation and early embryonic lethality.

Bijina Balakrishnan, Jan Verheijen, Arielle Lupo

Pageof 2

Frequent Collaborators

1 joint publications

Evelyn Llerena Cari

1 joint publications

Synneva Hagen-Lillevik

1 joint publications

Miriam Post

1 joint publications

Anton A Komar